Natixis has been supporting the Gustave Roussy Foundation since 2011 and is particularly involved in backing several teams working on cancer research.
Natixis has been supporting the Gustave Roussy Foundation since 2011 and is particularly involved in backing several teams working on cancer research.
Eric Solary, Director of Research at Gustave Roussy, as well as doctors Luc Friboulet, Sébastien Apcher and Gérard Mazon tell us about the work conducted over the past three years with Natixis’ support on:
- Clinical research on the MATCH-R trial to understand resistance to new treatments
- Fundamental research on tumor immunology and immunotherapy against cancer
- Fundamental research on repair mechanisms of DNA double-strand breaks.
As a result of Natixis’ support, leading European cancer center Gustave Roussy is able to welcome new skills and make progress in cancer research as it improves patient treatment and enhances their quality of life.
Do not miss anything! Receive an alert of upcoming news.
WHAT’S NEW
-
11-25-20 News | Podcast Green Momentum - Episode 3 I What room for energy transition in the recovery plans?
-
-
-
-
11-13-20 News | Interview Ostrum Asset Management – the creation of a European asset management leader
-
-
